Skip to Main Content

Client Success

On Behalf of Medtronic, Obtained Summary Judgment Dismissal of $55 Million Trade Secret Misappropriation Case

March 31, 2021

As lead defense counsel for Medtronic, Maslon obtained summary judgment dismissal of federal trade secret misappropriation claims worth $55 million and negotiated favorable settlement of related copyright infringement claims related to the company’s Abre venous stent.

In an amended complaint filed in March 2019, plaintiff Dr. Seshadri Raju—a vascular surgery specialist—named Medtronic a defendant in a significant, ongoing intellectual property dispute against his former business partner, Dr. Erin Murphy. In the original dispute, Raju accused Murphy of breaching a 2014 employment agreement that included non-compete provisions and a confidentiality agreement. Raju expanded the suit to include Medtronic upon discovering that Murphy had been hired by the medical device manufacturer to support FDA approval of the company’s Abre venous stent while still employed with Raju. Consequently, Raju alleged that Medtronic misappropriated his trade secrets and copyrighted materials in order to commercialize the product.

Raju’s claims against Medtronic included misappropriation of trade secrets, tortious interference with a contract, civil conspiracy, and copyright infringement. He sought $55 million in damages from Medtronic for the alleged trade secret misappropriation, plus $130,000 for alleged related copyright infringement.

After the Maslon team deposed key witnesses and brought the summary judgment motion, the U.S. District Court for the Southern District of Mississippi granted summary judgment in favor of Medtronic on all aspects of plaintiff’s trade secret misappropriation claims. The court also prevented plaintiff from seeking statutory damages or attorney's fees on related copyright infringement claims, which later settled on terms favorable to Medtronic. Maslon also obtained a ruling striking plaintiff's expert witness reports, while denying plaintiff's request to strike defendant's expert report.

The Maslon team included Bill Pentelovitch, Terry Newby, and Nate Ajouri. The case was Seshadri Raju, M.D., P.A. v. Medtronic, Inc. (No. 3:17-CV-357, S.D. Miss., March 2021).

DISCLAIMER

Thank you for your interest in contacting us by email.

Please do not submit any confidential information to Maslon via email on this website. By communicating with us we are not establishing an attorney-client relationship, and information you submit will not be protected by the attorney-client privilege and cannot be treated as confidential. A client relationship will not be formed until we have entered into a formal agreement. You should also be aware that we may currently represent parties whose interests may be adverse to yours, and we reserve the right to continue to represent them notwithstanding any communication we receive from you.

If you would like to discuss possible representation, please call one of our attorneys directly or use our general line (p 612.672.8200). We can then fully discuss our intake procedures and, if appropriate, introduce you to an attorney suited to assist with your matter. Alternatively, you may send us an email containing a general inquiry subject to these terms.

If you accept the terms of this notice and would like to send an email, click on the "Accept" button below. Otherwise, please click "Decline."

MEDIA INQUIRIES

We welcome the opportunity to assist you with your media inquiry. To ensure we do so properly and promptly, please feel free to contact our representative below directly by phone or via the email option provided. We look forward to hearing from you.

Emily Gurnon, Marketing Communications Manager | Office: 612.672.8251 | Mobile: 651.785.3616

EMAIL DISCLAIMER

This email is intended for use by members of the media only.

Please do not submit any confidential information to Maslon via email on this website. By communicating with us we are not establishing an attorney-client relationship, and information you submit will not be protected by the attorney-client privilege and cannot be treated as confidential. A client relationship will not be formed until we have entered into a formal agreement. You should also be aware that we may currently represent parties whose interests may be adverse to yours, and we reserve the right to continue to represent them notwithstanding any communication we receive from you.

If you would like to discuss possible representation, please call one of our attorneys directly or use our general line (p 612.672.8200). We can then fully discuss our intake procedures and, if appropriate, introduce you to an attorney suited to assist with your matter. Alternatively, you may send an email containing a general inquiry subject to these terms.

If you are a member of the media, accept the terms of this notice, and would like to send an email, click on the "Accept" button below. Otherwise, please click "Decline."